Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
4.25 EUR | +1.19% | +38.44% | -36.57% |
05-06 | Carmat: progress in ongoing clinical study | CF |
05-06 | CARMAT Continues to Build on Its Momentum in the EFICAS Study | CI |
- Stock Market
- Equities
- ALCAR Stock
- Charts CARMAT
- Total Return chart